Efficacy and Safety of Ipilimumab plus Chemotherapy for Advanced Lung Cancer: A Systematic Review and Meta-Analysis

Lung cancer is the leading cause of cancer-related deaths worldwide, with poor prognosis in advanced lung cancer patients. Platinum-based chemotherapy has always been a first-line treatment for the majority of advanced lung cancer patients, but its long-term survival benefit is limited. Ipilimumab i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongman, Shen, Jie, Yi, Lilan, Zhang, Wei, Luo, Peng, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277638/
https://www.ncbi.nlm.nih.gov/pubmed/30519362
http://dx.doi.org/10.7150/jca.27368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277638/
https://www.ncbi.nlm.nih.gov/pubmed/30519362
http://dx.doi.org/10.7150/jca.27368

Ejemplares similares